[go: up one dir, main page]

BR0009897A - Produto farmacêutico - Google Patents

Produto farmacêutico

Info

Publication number
BR0009897A
BR0009897A BR0009897-3A BR0009897A BR0009897A BR 0009897 A BR0009897 A BR 0009897A BR 0009897 A BR0009897 A BR 0009897A BR 0009897 A BR0009897 A BR 0009897A
Authority
BR
Brazil
Prior art keywords
compound
provides
pharmaceutical
containing peaks
bemzi
Prior art date
Application number
BR0009897-3A
Other languages
English (en)
Inventor
Paul David James Blackler
Robert Gordon Giles
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR0009897A publication Critical patent/BR0009897A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

"PRODUTO FARMACêUTICO". A presente invenção refere-se a um diidrato de cloridrato de 5-[4-[2-(N-metil-N-(2-piridil)amino)etóxi]bemzi]tiazolidina-2,4-diona caracterizado pelo fato de que ele: (i) proporciona um espectro infravermelho contendo picos em 3392, 2739, 1751, 1325 e 713 cm-^ 1^, e/ou (ii) proporciona um padrão de difração em pó de raio X (XRPD) contendo picos em 9, 1, 12, 0, 15, 7, 16,3 e 19, 8<198>20, um processo para a preparação do composto, uma composição farmacêutica contendo tal composto e o uso de do composto em medicina.
BR0009897-3A 1999-04-20 2000-04-19 Produto farmacêutico BR0009897A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909041.7A GB9909041D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical
PCT/GB2000/001521 WO2000063205A2 (en) 1999-04-20 2000-04-19 Thiazolidinedione derivative and its use as antidiabetic

Publications (1)

Publication Number Publication Date
BR0009897A true BR0009897A (pt) 2002-04-16

Family

ID=10851901

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009897-3A BR0009897A (pt) 1999-04-20 2000-04-19 Produto farmacêutico

Country Status (42)

Country Link
EP (2) EP1173436B1 (pt)
JP (2) JP4283449B2 (pt)
KR (1) KR100601244B1 (pt)
CN (2) CN101134756A (pt)
AP (1) AP1562A (pt)
AR (2) AR023566A1 (pt)
AT (1) ATE268770T1 (pt)
AU (2) AU4130900A (pt)
BG (1) BG65864B1 (pt)
BR (1) BR0009897A (pt)
CA (1) CA2382036A1 (pt)
CO (1) CO5170422A1 (pt)
CZ (1) CZ300653B6 (pt)
DE (1) DE60011419T2 (pt)
DK (1) DK1173436T3 (pt)
DZ (1) DZ3162A1 (pt)
EA (1) EA004232B1 (pt)
EG (1) EG24063A (pt)
ES (1) ES2218146T3 (pt)
GB (1) GB9909041D0 (pt)
HK (1) HK1045151B (pt)
HR (1) HRP20010770B1 (pt)
HU (1) HUP0200865A3 (pt)
IL (1) IL146078A0 (pt)
MA (1) MA26783A1 (pt)
MX (1) MXPA01010696A (pt)
MY (1) MY126034A (pt)
NO (1) NO320609B1 (pt)
NZ (1) NZ515166A (pt)
OA (1) OA11866A (pt)
PE (1) PE20010050A1 (pt)
PL (1) PL351135A1 (pt)
PT (1) PT1173436E (pt)
RS (1) RS50136B (pt)
SI (1) SI1173436T1 (pt)
SK (1) SK284991B6 (pt)
TR (1) TR200103040T2 (pt)
TW (1) TWI277616B (pt)
UA (1) UA71615C2 (pt)
UY (1) UY26112A1 (pt)
WO (1) WO2000063205A2 (pt)
ZA (1) ZA200108720B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
PT1448559E (pt) * 2001-11-21 2007-03-30 Smithkline Beecham Plc Benzenossulfonato de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)benzil)tiazolidina-2, 4-diona; processo para a sua preparação; seus polimorfos i, ii e iii; e sua utilização como ingrediente farmacêutico activo
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
CZ296468B6 (cs) * 2004-06-10 2006-03-15 Zentiva, A. S. Sul kyseliny fosforecné s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionema zpusob její prípravy
CZ296472B6 (cs) * 2004-07-27 2006-03-15 Zentiva, A. S Sul kyseliny stavelové s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu azpusob její prípravy a její pouzití
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
EP1173436A2 (en) 2002-01-23
SK284991B6 (sk) 2006-04-06
GB9909041D0 (en) 1999-06-16
EA004232B1 (ru) 2004-02-26
EA200101101A1 (ru) 2002-04-25
BG65864B1 (bg) 2010-03-31
HRP20010770A2 (en) 2002-10-31
AP2001002331A0 (en) 2000-04-19
UY26112A1 (es) 2000-12-29
JP2009143954A (ja) 2009-07-02
ES2218146T3 (es) 2004-11-16
UA71615C2 (uk) 2004-12-15
SI1173436T1 (en) 2004-12-31
AU4130900A (en) 2000-11-02
RS50136B (sr) 2009-03-25
DE60011419T2 (de) 2005-06-16
MY126034A (en) 2006-09-29
AR023562A1 (es) 2002-09-04
OA11866A (en) 2006-03-02
TR200103040T2 (tr) 2002-04-22
DK1173436T3 (da) 2004-09-27
KR100601244B1 (ko) 2006-07-19
HUP0200865A3 (en) 2005-04-28
DE60011419D1 (de) 2004-07-15
PE20010050A1 (es) 2001-03-10
HK1045151A1 (en) 2002-11-15
CN101134756A (zh) 2008-03-05
ZA200108720B (en) 2002-11-28
MXPA01010696A (es) 2002-06-04
PT1173436E (pt) 2004-10-29
CN1327447A (zh) 2001-12-19
BG106112A (bg) 2002-05-31
AU2755202A (en) 2002-05-16
DZ3162A1 (fr) 2000-10-26
SK14902001A3 (sk) 2002-02-05
TWI277616B (en) 2007-04-01
AU765911B2 (en) 2003-10-02
WO2000063205A2 (en) 2000-10-26
HK1045151B (zh) 2005-03-18
AP1562A (en) 2006-02-01
WO2000063205A3 (en) 2001-01-25
CO5170422A1 (es) 2002-06-27
HUP0200865A2 (en) 2002-08-28
ATE268770T1 (de) 2004-06-15
PL351135A1 (en) 2003-03-24
CA2382036A1 (en) 2000-10-26
IL146078A0 (en) 2002-07-25
NO20015104D0 (no) 2001-10-19
JP4283449B2 (ja) 2009-06-24
KR20010110791A (ko) 2001-12-13
AR023566A1 (es) 2002-09-04
EP1411055A1 (en) 2004-04-21
NO20015104L (no) 2001-12-19
MA26783A1 (fr) 2004-12-20
CZ300653B6 (cs) 2009-07-08
EG24063A (en) 2008-05-08
YU81501A (sh) 2004-07-15
HRP20010770B1 (en) 2005-06-30
JP2002542242A (ja) 2002-12-10
EP1173436B1 (en) 2004-06-09
NZ515166A (en) 2004-02-27
NO320609B1 (no) 2005-12-27
CZ20013759A3 (cs) 2002-05-15

Similar Documents

Publication Publication Date Title
BR0009932A (pt) Polimorfo de sal de ácido maléico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etóxi]benzil]tiazolidi na-2,4-diona
YU36400A (sh) Supstituisani tiazolidinedion derivat, postupak za njegovo dobijanje i njegova farmaceutska primena
BR0009934A (pt) Produto farmacêutico
BR0009935A (pt) Produto farmacêutico
BR0009897A (pt) Produto farmacêutico
BR9813604A (pt) Hidrato de sal de ácido maleico 5-[4-[2- (n-metil-n-(2-piridil) amino) etóxi]benzil]tiazolidina-2,4-diona
BR0009898A (pt) Produto farmacêutico
MY135973A (en) Modified release compositions comprising 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, optionally in the form of pharmaceutically acceptable derivative
BR9810405A (pt) Composição que compreende 5-[4-[2-(n-metil-n-2-piridil) amino) etoxi] benzil] tiazolidino-2,4-diona
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
BR0113713A (pt) Sal de cloridrato de 5-[4-[2-(metil-n-(2-piridil)amino)etóxi]benzil]tiazolidina -2,4-diona
HK1057204A1 (en) A thiazolidinedione derivative and its use as antidiabetic
ECSP003435A (es) Nuevos compuestos
ECSP003434A (es) Nuevos compuestos
AP1813A (en) Tartrate salts of thiazolidinedione derivative.
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
NZ510672A (en) Composition comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)-Ethoxy]Benzyl]Thiazolidine-2,4-Dione
ECSP003436A (es) Nuevos compuestos
ECSP003438A (es) Nuevos compuestos

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13, 24 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.